Ranting Qian Overview
- Firm
- Lake Bleu Capita...
- Primary Position
-
Partner
- Primary Industry
-
Healthcare
- Active Board Seats
-
1
- Med. Deal Size
-
Ranting Qian General Information
Biography
Ms. Ranting Qian serves as Partner at Lake Bleu Capital. She serves as Board Member at AffaMed Therapeutics. She has 16 years of experience in China healthcare investment and business operations. She joined Lake Bleu Capital in early 2018 and has since accomplished investment into over 40 mid-to-late-stage private companies in China's healthcare sector. Prior to joining LBC, she worked as Sanofi Asia business development director, and successfully led and completed major asset restructuring for Sanofi China consumer healthcare business unit. Before that, she spent 9 years with China Nepstar Chain Drugstore as VP and company secretary. She has an MBA from CEIBS and a Master of Finance & development from London University. She also owns a fellowship from ACCA.
Contact Information
Address
- Unit 1202-03 12/F Wheelock House
- 20 Pedder Street, Central
- Hong Kong, 852
- Hong Kong
Ranting Qian Positions (1)
| Firm name | Firm type | Title | Location | Industry | Since |
|---|---|---|---|---|---|
| Lake Bleu Capital | Investor | Partner | Hong Kong, Hong Kong | Hedge Fund |
Ranting Qian Board Seats (1)
| Company | Industry | Ownership Status | Financing Status | Location | Since |
|---|---|---|---|---|---|
| AffaMed Therapeutics | Drug Discovery | Privately Held (backing) | Private Equity-Backed | Shanghai, China |
Ranting Qian Lead Partner on Deals (4)
Ranting Qian has been the lead partner on 4 deals. Their latest deal was with Zelixir Biotech, a drug discovery company. The deal was made for on 25-May-2023.
| Company | Deal Date | Deal Type | Deal Size | Deal Status | Industry | Location |
|---|---|---|---|---|---|---|
| Zelixir Biotech | 25-May-2023 | Early Stage VC (Series A) | Completed | Drug Discovery | Shanghai, China | |
| Bangbang Robotics | 29-Jun-2022 | Completed | Automotive | Shanghai, China | ||
| Synthgene | 21-Mar-2022 | Early Stage VC (Series A1) | Completed | Medical Supplies | Nanjing, China | |
| CH Biomedical | 13-Aug-2021 | Later Stage VC (Series D) | Completed | Therapeutic Devices | Suzhou, China |
Ranting Qian Network (12)
Board Members (8)
| Name | Company | Representing | Location | From |
|---|---|---|---|---|
| Fay Xing Ph.D | AffaMed Therapeutics | Self | Shanghai, China | |
| Dayao Zhao Ph.D | AffaMed Therapeutics | AffaMed Therapeutics | Shanghai, China | |
| AffaMed Therapeutics | CBC Group | Shanghai, China | ||
| AffaMed Therapeutics | Self | Shanghai, China | ||
| AffaMed Therapeutics | AffaMed Therapeutics | Shanghai, China |
Portfolio Executives (4)
| Name | Company | Role | Deal date | Location |
|---|---|---|---|---|
| Sheng Wang Ph.D | Zelixir Biotech | Chief Executive Officer & Chairman | 25-May-2023 | Shanghai, China |
| Jianguo Li | Bangbang Robotics | Founder & Chief Executive Officer | 29-Jun-2022 | Shanghai, China |
| Synthgene | Chairman & Chief Executive Officer | 21-Mar-2022 | Nanjing, China | |
| CH Biomedical | Co-Founder & Chief Executive Officer | 13-Aug-2021 | Suzhou, China |
Ranting Qian Affiliated Funds (1)
| Fund | Investor | Fund Type | Status | Vintage | Size | Dry Powder | IRR | IRR Quartile |
|---|---|---|---|---|---|---|---|---|
| LBC Sunshine Healthcare Fund II | Lake Bleu Capital | Buyout | Closed | 2021 |
Ranting Qian FAQs
-
Who is Ranting Qian?
Ms. Ranting Qian serves as Partner at Lake Bleu Capital.
-
How much does Ranting Qian typically invest?
Ranting Qian's median deal size is .
-
What is Ranting Qian’s main position?
Ranting Qian’s primary position is Partner.
-
What are the contact details for Ranting Qian?
Ranting Qian’s email address is lu and his phone number is +852 2503 .
-
How many active board seats does Ranting Qian hold?
Ranting Qian holds a board seat in AffaMed Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
